Is the coronavirus on its way out?
You might think so. New, updated booster shots are being rolled out to better protect against the variants circulating now. The U.S. Centers for Disease Control and Prevention has dropped COVID-19 quarantine and distancing recommendations. And more people have thrown off their masks and returned to pre-pandemic activities.
But scientists say no. They predict the scourge that’s already lasted longer than the 1918 flu pandemic will linger far into the future.
One reason it’s lasted this long? It’s gotten better and better at getting around immunity from vaccination and past infection. Scientists point to emerging research that suggests the latest omicron variant gaining ground in the U.S. — BA.4.6, which was responsible for around 8% of new U.S. infections last week — appears to be even better at evading the immune system than the dominant BA.5.
Scientists worry the virus may well keep evolving in worrisome ways.
How long will it be around?
White House COVID-19 coordinator Dr. Ashish Jha said COVID-19 will likely be with us for the rest of our lives.
Experts expect COVID-19 will someday become endemic, meaning it occurs regularly in certain areas according to established patterns. But they don’t think that will be very soon.
Still, living with COVID “should not necessarily be a scary or bad concept,” since people are getting better at fighting it, Jha said during a recent question-and-answer session with U.S. Sen. Bernie Sanders of Vermont. “Obviously if we take our foot off the gas — if we stop updating our vaccines, we stop getting new treatments — then we could slip backwards.”
Experts say COVID will keep causing serious illness in some people. The COVID-19 Scenario Modeling Hub made some pandemic projections spanning August 2022 to May 2023, assuming the new tweaked boosters adding protection for the newest omicron relatives would be available and a booster campaign would take place in fall and winter. In the most pessimistic scenario — a new variant and late boosters — they projected 1.3 million hospitalizations and 181,000 deaths during that period. In the most optimistic scenario — no new variant and early boosters — they projected a little more than half the number of hospitalizations and 111,000 deaths.
Eric Topol, head of Scripps Research Translational Institute, said the world is likely to keep seeing repetitive surges until “we do the things we have to do,” such as developing next generation vaccines and rolling them out equitably.
Topol said the virus “just has too many ways to work around our current strategies, and it’ll just keep finding people, finding them again, and self-perpetuating.”
How will the virus mutate?
Scientists expect more genetic changes that affect parts of the spike protein studding the surface of the virus, letting it attach to human cells.
But the virus probably won’t keep getting more transmissible forever.
“I think there is a limit,” said Matthew Binnicker, director of clinical virology at Mayo Clinic in Rochester, Minnesota. “What we’re really dealing with, though, is there’s still a lot of people across the world who don’t have any prior immunity — either they haven’t been infected or they haven’t had access to vaccination.”
If humanity’s baseline level of immunity rises significantly, he said, the rate of infections, and with that emergence of more contagious variants, should slow down.
But there is a chance the virus could mutate in a way that causes more severe illness.
“There’s not any inherent reason, biologically, that the virus has to become milder over time,” said Dr. Wesley Long, a pathologist at Houston Methodist. The fact it may seem milder now “is likely just the combined effect of all of us having some immune history with the virus.”
While scientists hope that continues, they also point out that immunity gradually wanes.
Will the next variant be another version of Omnicron?
Omicron has been around since late last year, with a series of super transmissible versions quickly displacing one another, and Binnicker believes “that will continue at least for the next few months.”
But down the road, he said it’s likely a new variant distinct from omicron will pop up.
The recent wave of infections and re-infections, he said, “gives the virus more chances to spread and mutate and new variants to emerge.”
Can people influence the future of the virus?
Yes, experts said. One way is to get vaccinated and boosted.
“We have a virus out there that’s still circulating, still killing hundreds of Americans every day,” Jha said in a press briefing Tuesday. But, he added: “We now have all of the capability to prevent, I believe, essentially all of those deaths. If people stay up to date on their vaccines, if people get treated if they have a breakthrough infection, we can make deaths from this virus vanishingly rare.”
Not only does vaccination protect against severe disease and death, it raises the level of immunity globally.
CDC director Rochelle Walensky said Tuesday that up to 100,000 COVID-19 hospitalizations and 9,000 deaths could be prevented if Americans get the updated booster at the same rate they typically get an annual flu shot this fall. About half of Americans are typically vaccinated against the flu each year.
People can also keep protecting themselves by taking other precautions like, for example, wearing masks indoors when COVID rates are high.
Longtime nurse Catherine Mirabile said it’s important not to dismiss the dangers of the coronavirus — which sickened her twice, nearly killed her husband and left them both with long COVID. Daily deaths still average around 450 in the U.S.
“People really need to look at this and still take this seriously,” said the 62-year-old from Princeton, West Virginia, who is now on disability. “They could end up in the same shape we’re in.”
News
This Deadly Disease Was Wiping Out Humans 5,500 Years Ago
A new study suggests plague was already a deadly threat 5,500 years ago, striking small hunter-gatherer communities long before cities and agriculture emerged. For centuries, plague has been remembered as the disease that devastated [...]
China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new [...]
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
Artificial cells gain porous membranes, enabling lab reactions and drug release
Artificial cells created in the laboratory offer a wide range of potential applications. Until now, however, their membranes—unlike those of real cells—have been virtually impermeable. Researchers at the Max Planck Institute for Polymer Research, [...]
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]
AI-designed universal coronavirus vaccine clears first human trial
Key Takeaways Super-Antigen Technology: Uses AI and machine learning to analyze viral genomes, creating a single vaccine that targets essential features across entire virus families, including coronaviruses and Ebola. Human Trials & Safety: Phase [...]
Researchers Discover a Hidden Vitamin D Problem That Persists Year-Round
A new study suggests that some groups may not experience the expected seasonal boost in vitamin D levels, even during the sunniest months of the year. Many people assume that spending more time outdoors [...]















